Wegovy vs. Zepbound when both cost $50
Published by GLP-1 Coverage Guide · Updated · No clinician review is credited for this page.
Short answer: Wegovy and Zepbound have the same $50 copay for authorized Bridge fills, but formulations and indications differ. The Bridge includes Wegovy injections and tablets, and only Zepbound KwikPen. The clinical choice belongs with your prescriber.
Sources for the coverage rules are listed below. An update date marks a revision; it does not imply a sitewide medical review.
Compare the prescribed indication first
A drug chosen for a Part D-covered indication follows the regular plan route. In particular, cardiovascular-risk reduction in established cardiovascular disease is different from a weight-management-only Bridge prescription; moderate-to-severe sleep apnea is also a Part D routing condition.
Ask the prescriber to explain the relevant form-specific label, your medical history, interactions and follow-up. This comparison does not predict your weight loss or infer suitability from trial averages.
Compare dispensing and added costs
Confirm the exact covered formulation and local availability. Zepbound KwikPen needles are separate purchases; provider visits or optional service memberships may add fees to either route. Compare written totals for the same supply length instead of comparing a medication copay with an all-in advertised membership price.
Take the Medicare eligibility check →
Common questions
Does the $50 copay guarantee treatment is appropriate?
No. Eligibility, authorization, pharmacy supply and clinical suitability are separate checks.
Can I change the dose or formulation myself?
Discuss changes with your prescriber and pharmacist. Follow the prescribed instructions and current form-specific labeling.
Related
Sources: CMS covered formulations and process · CMS prior authorization form